Project title: Non-Invasive Bionic Vision Wearable Development Prototype for Blind and Vision Impaired
ARIA Research Pty Ltd has developed a world-first solution to the chronic burdens of blindness and vision-impairment, which impact 687,000 Australians and over 338 million people worldwide.
In February 2021, the ARIA MVP system exceeded the real-world performance of bionic eye systems. The ARIA device provides a vision-analogous sense to its blind users via their natural sense of hearing. ARIA enables blind users, within seconds of putting on the ARIA glasses, to experience an intuitive, detailed, real-time 3D perception of the layout of a space, identifying, locating, moving among, and reaching/grasping objects within it.
ARIA is a type IIa medical device, an Electronic Vision Aid, that delivers benefit to users, regardless of the underlying pathology of their vision loss. ARIA is non-surgical and non-invasive, providing immediate benefit with minimal training, and is non-fatiguing, able to be worn as an all-day, every-day device.
ARIA is Australian conceived, developed, and owned, with a roadmap to manufacture, clinical trial, and launch to NDIS participants within 3 years.
BMTH Project Round: Four
State: New South Wales
- Manufacturing partner: Genesys Designs Pty Ltd
- Research Partners: Guide Dogs NSW & ACT, University of Sydney, World Access for the Blind Australia Limited, UTS
- MTPConnect Grant: $800,000
- Industry Contribution: $1,094,263
Duration: October 2021 - September 2022